A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

The first report to compare what pharmaceutical companies are doing to bring antimicrobial resistance under control. By highlighting innovative actions, it encourages more companies to seize opportunities for change.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

News

All the latest news about the Access to Medicine Foundation, our research programmes and engagement activities. 

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

03 Aug 2018

New paper explains expanded Index focus on global health R&D

A new article published in Health Research Policy and Systems sets out how the 2018 Access to Medicine Index will analyse pharmaceutical companies R&D...

02 Aug 2018

Data analysis gathers pace for 2018 Access to Medicine Index

The 2018 Access to Medicine Index will be the 6th ranking of the world’s largest pharmaceutical companies on their access-to-medicine performances. We...

13 Jul 2018

Index added to new online toolbox for impact investors

The Access to Medicine Index and AMR Benchmark have been added to Navigating Impact, a new online resource centre developed specifically for impact in...

27 Jun 2018

Experts gather to discuss proposals for 2020 Antimicrobial Resistance Benchmark

On 2 July 2018, the Foundation's Expert Committee will meet in Amsterdam to discuss methodology proposals for the next Antimicrobial Resistance B...

08 Jun 2018

Access to Medicine Index gains first Japanese signatory investor

Sumitomo Mitsui Trust Holdings is the latest investor to publicly endorse the Access to Medicine Index, becoming the 68th signatory to the Index inves...

31 May 2018

Access to Medicine Foundation makes case for fixing the antibiotic market

Today, the Access to Medicine Foundation warns that antibiotic supply chains are on the brink of collapse, putting basic healthcare at risk, in a new...

18 May 2018

Foundation to co-host events at WHO World Health Assembly

Jayasree K. Iyer, Executive Director, will speak at two events being co-hosted by the Foundation at the 71st WHO World Health Assembly (WHA). On Tuesd...

19 Apr 2018

Work starts on metrics for the 2020 AMR Benchmark

The Access to Medicine Foundation has started the methodology review for the next Antimicrobial Resistance Benchmark. The Foundation is consulting a w...

12 Mar 2018

Access to Medicine Foundation in India to discuss AMR strategies

India is home to more than a billion people, who face increasing rates of drug resistance. From 12-16 March, the Access to Medicine Foundation will be...

21 Feb 2018

New IP-sharing framework to accelerate R&D

The Access to Medicine Foundation has worked with BIO Ventures for Global Health (BVGH) to develop a framework for identifying which IP assets are mos...

09 Feb 2018

Want to work at the Access to Medicine Foundation? We’re hiring!

The Access to Medicine Foundation started in 2003 with a single idea: to encourage pharmaceutical companies to compete to be the best at helping the w...

25 Jan 2018

Live WEF discussion with Bill Gates & Jayasree Iyer at 1pm CET: “New Era For Global Health”

Jayasree K. Iyer joins Bill Gates and others to discuss how new leadership, policy and business models are rewriting the global health playbook.

23 Jan 2018

The first Benchmark launches at the WEF in Davos

At 14:00 CET on Tuesday 23 January, Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, will launch the first Antimicrobial Res...

23 Jan 2018

Now published: first independent comparison of pharma companies’ efforts to address drug-resistant infections

Amsterdam, Davos, 23 January 2018 – The first independent analysis of pharmaceutical industry efforts to tackle drug resistance, published today, find...

19 Jan 2018

Watch the live launch of the Antimicrobial Resistance Benchmark – on Tues 23 Jan

Starting at 14:00 CET on Tuesday 23 January, Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, will present the results of th...

12 Jan 2018

A look back at a year of vaccine announcements

Since we published the Access to Vaccines Index in March 2017, vaccine companies have reported a series of positive developments in their efforts to a...

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.